Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience

BACKGROUND: Despite growing use of the subcutaneous implantable cardioverter‐defibrillator (S‐ICD), its clinical role in arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) patients remains undefined. We aim to elucidate the cardiac phenotype, implant characteristics, and long‐term ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Orgeron, Gabriela M., Bhonsale, Aditya, Migliore, Federico, James, Cynthia A., Tichnell, Crystal, Murray, Brittney, Bertaglia, Emanuele, Cadrin‐Tourigny, Julia, De Franceschi, Pietro, Crosson, Jane, Tandri, Harikrishna, Corrado, Domenico, Calkins, Hugh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404172/
https://www.ncbi.nlm.nih.gov/pubmed/30608223
http://dx.doi.org/10.1161/JAHA.118.008782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404172/
https://www.ncbi.nlm.nih.gov/pubmed/30608223
http://dx.doi.org/10.1161/JAHA.118.008782

Ejemplares similares